SRC and breast cancer: In vitro analysis showed that KX-01 extremely induced apoptosis in MDA-MB-468 cells (human breast cancer cell line) at 25 nmol/L, whereas dasatinib (specific Src/tyrosine kinase inhibitor) did not induce apoptosis at a × 10 higher concentration (Lahdenranta et al. 2007; Anbalagan et al. 2017).